ISEE Overview
Upcoming Projects (ISEE)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (ISEE)
-
Quarterly Survey: Geographic Atrophy (GA) Treatments including Apellis' Syfovre and Iveric Bio's Izervay January 2024
Tickers: APLS, ISEE
Executed On: Jan 23, 2024 at 04:40 PM EST -
Quarterly Survey: Geographic Atrophy (GA) Treatments including Apellis' Syfovre and Iveric Bio's Izervay October 2023
Tickers: APLS, ISEE
Executed On: Oct 26, 2023 at 02:24 PM EDT -
Quarterly Survey: Geographic Atrophy (GA) / Apellis' Syfovre and the impact of the Adverse Event Reports - July 2023
Tickers: APLS, ISEE
Executed On: Aug 01, 2023 at 03:28 PM EDT -
A Third Look: Understanding the impact of 6 reported cases of inflammation in patients receiving Syfovre injections
Tickers: APLS, ISEE
Executed On: Jul 20, 2023 at 03:00 PM EDT -
A Second Look: Understanding the impact of 6 reported cases of inflammation in patients receiving Syfovre injections
Tickers: APLS, ISEE
Executed On: Jul 19, 2023 at 04:00 PM EDT -
Understanding the impact of 6 reported cases of inflammation in patients receiving Syfovre injections
Tickers: APLS, ISEE
Executed On: Jul 18, 2023 at 09:00 AM EDT -
2 Week Delay: Apellis Pharmaceuticals' Pegcetacoplan GA Label and Pricing Individual Results
Tickers: APLS, ISEE
Executed On: Mar 13, 2023 at 05:39 PM EDT -
A Second View: Digging into the topline data from Iveric Bio's Zimura GATHER2 Phase 3 Clinical Trial in Geographic Atrophy and how it compares to Apellis' EMPAVELI
Tickers: ISEE, APLS
Executed On: Sep 09, 2022 at 01:30 PM EDT -
Digging into the topline data from Iveric Bio's Zimura GATHER2 Phase 3 Clinical Trial in Geographic Atrophy
Tickers: ISEE, APLS
Executed On: Sep 07, 2022 at 04:30 PM EDT
Upcoming & Overdue Catalysts (ISEE)
-
Don’t see a catalyst related to the company you care about? Create your own!
Strategic Initiatives (ISEE)
-
Don’t see a strategic initiative related to the company you care about? Create your own!
